InvestorsHub Logo
Followers 66
Posts 1221
Boards Moderated 0
Alias Born 04/02/2020

Re: Stockpennies post# 92017

Wednesday, 07/08/2020 4:12:51 PM

Wednesday, July 08, 2020 4:12:51 PM

Post# of 232073
Am I correct in recalling a post (posts) that stated it was likely CytoDyn and/or Dr. Patterson were getting all the blind data from the ongoing trials. The inference being that Dr. Patterson would likely be able to distinguish which data sets were Leronlimab vs Placebo.

If my recollection is accurate, wouldn’t it have been to CytoDyn’s advantage from a credibility perspective to recommend haughting trials in the same manner in which other trials were haughted?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News